Benefits of a nationwide population-based skin cancer screening programme - still a controversial debate
- PMID: 34605008
- DOI: 10.1111/bjd.20709
Benefits of a nationwide population-based skin cancer screening programme - still a controversial debate
Comment on
-
Are patients benefiting from participation in the German skin cancer screening programme? A large cohort study based on administrative data.Br J Dermatol. 2022 Jan;186(1):69-77. doi: 10.1111/bjd.20658. Epub 2021 Oct 4. Br J Dermatol. 2022. PMID: 34289097
Similar articles
-
Skin Cancer-The Importance of Prevention.JAMA Intern Med. 2016 Oct 1;176(10):1435-1436. doi: 10.1001/jamainternmed.2016.5008. JAMA Intern Med. 2016. PMID: 27459394 Free PMC article. No abstract available.
-
Skin cancer rates in North Rhine-Westphalia, Germany before and after the introduction of the nationwide skin cancer screening program (2000-2015).Eur J Epidemiol. 2018 Mar;33(3):303-312. doi: 10.1007/s10654-017-0348-6. Epub 2018 Jan 2. Eur J Epidemiol. 2018. PMID: 29294207
-
Prevalence and correlates of skin cancer screening among middle-aged and older white adults in the United States.Am J Med. 2010 Dec;123(12):e11; author reply e13-e14. doi: 10.1016/j.amjmed.2010.06.020. Epub 2010 Oct 19. Am J Med. 2010. PMID: 20961521 No abstract available.
-
Effectiveness of skin cancer screening programmes.Br J Dermatol. 2012 Aug;167 Suppl 2:94-8. doi: 10.1111/j.1365-2133.2012.11091.x. Br J Dermatol. 2012. PMID: 22881593 Review.
-
[Skin cancer screening in Germany: review after ten years].Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Dec;61(12):1536-1543. doi: 10.1007/s00103-018-2836-6. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018. PMID: 30411137 Review. German.
Cited by
-
Skin Cancer Screening and Medical Treatment Intensity in Patients with Malignant Melanoma and Non-Melanocytic Skin Cancer.Dtsch Arztebl Int. 2023 Jan 20;120(3):33-39. doi: 10.3238/arztebl.m2022.0364. Dtsch Arztebl Int. 2023. PMID: 36471642 Free PMC article.
References
-
- Stang A, Jöckel K-H. Does skin cancer screening save lives? A detailed analysis of mortality time trends in Schleswig-Holstein and Germany. Cancer 2016; 122:432-7.
-
- Breitbart EW, Choudhury K, Anders MP et al. Benefits and risks of skin cancer screening. Oncol Res Treat 2014; 37 (Suppl. 3):38-47.
-
- Datzmann T, Schoffer O, Meier F et al. Patients benefit from participating in the German skin cancer screening program? A large cohort study based on administrative data. Br J Dermatol 2022; 186:69-77.
-
- Avilés-Izquierdo JA, Molina-López I, Rodríguez-Lomba E et al. Who detects melanoma? Impact of detection patterns on characteristics and prognosis of patients with melanoma. J Am Acad Dermatol 2016; 75:967-74.
-
- Stang A EvaSCa - Evaluation des Hautkrebsscreenings bei AOK-Versicherten in Deutschland. Available at: https://innovationsfonds.g-ba.de/projekte/versorgungsforschung/evasca-ev... (last accessed 24 September 2021).
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical